Evidence map›Paper›PMID 36143406›Full record

ArticleLife (Basel, Switzerland)2022

Hany Ezzat Khalil, Miada F Abdelwahab, Promise Madu Emeka, Lorina I Badger-Emeka, Al-Shaimaa F Ahmed, Aliaa F Anter, Sara Mohamed Naguib Abdel Hafez, Khalid A AlYahya, Hairul-Islam Mohamed Ibrahim, Krishnaraj Thirugnanasambantham and 2 more

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Hany Ezzat KhalilDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0001-7892-3380
Miada F AbdelwahabDepartment of Pharmacognosy, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.ORCID 0000-0001-6597-0487
Promise Madu EmekaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0003-1943-1874
Lorina I Badger-EmekaDepartment of Biomedical Sciences, College of Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0002-9201-6215
Al-Shaimaa F AhmedDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.ORCID 0000-0001-9875-6399
Aliaa F AnterDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
Sara Mohamed Naguib Abdel HafezDepartment of Histology and Cell Biology, Faculty of Medicine, Minia University, Minia 61519, Egypt.ORCID 0000-0003-3901-2802
Khalid A AlYahyaDepartment of Surgery, College of Medicine, King Faisal University, Al-Ahsa 36363, Saudi Arabia.ORCID 0000-0002-3434-8035
Hairul-Islam Mohamed IbrahimDepartment of Biological Sciences, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0002-2444-5552
Krishnaraj ThirugnanasambanthamPondicherry Centre for Biological Science and Educational Trust, Puducherry 605004, India.ORCID 0000-0002-5340-8806
Katsuyoshi MatsunamiDepartment of Pharmacognosy, Graduate School of Biomedical & Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan.ORCID 0000-0002-8034-0253
Alyaa Hatem Ibrahim SelimDepartment of Pharmacognosy, Faculty of Pharmacy, Sohag University, Sohag 82524, Egypt.
King Faisal University · SAMinia University · EGHiroshima University · JPSaveetha University · INSohag University · EG

Funding

the Deanship of Scientific Research (DSR), King Faisal University, Saudi ‎Arabia, ‎for funding this research group project 1811002
6 · The paper itself

Abstract

backgroundRecently, crop byproducts are considered a hot topic and can be converted into beneficial products. Cauliflower is well-known for its protective effects against oxidative stress-induced damage. The current study aimed to investigate the chemical profile and the ameliorative effects of cauliflower leaf extract (CL) on gentamicin-induced renal and hepatic injuries in rats.

methodsCauliflower leaf was extracted with methanol to give the total methanol extract (TME) followed by the determination of total phenolic contents (TPC). Rats were divided into five groups; Group I was assigned as the control group, while the other groups were injected with gentamicin for ten days. Group II was given distilled water. Rats in groups III and IV were treated with oral CL (200 mg/kg and 400 mg/kg, respectively). Group V received L-cysteine (as a positive control). The functions of the kidneys and liver; oxidative stress and morphological and apoptotic changes of renal and hepatic tissues were assessed.

resultsThe TME was subjected to chromatographic techniques to yield ferulic acid, vanillic acid, p-coumaric acid and quercetin. TPC was 72.31 mg GAE/g of dried extract. CL treatment dose-dependently ameliorated gentamicin-induced impaired kidney and liver functions and improved the histopathological appearance of both organs. It also reduced gentamicin-induced oxidative stress. CL demonstrated downregulation of mRNA and protein expressions of IL-1β and NF-κB compared to nontreated rats. In silico interaction of the isolated compounds with amino acid residues of IL-1β and NF-κB might explain the current findings.

conclusionTaken together, this study raises the waste-to-wealth potential of cauliflower to mitigate gentamicin-induced hepatorenal injury and convert the waste agromaterials into valuable products.

Indexed as

ASTBrassica oleraceacauliflowercreatininegentamicinGSHIL-1βNF-κB

Identifiers

PMID36143406
PMCPMC9504091
OpenAlexW4295067669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.